AAAAAA
Results: 76-100/238
Authors:
Graham, DY
Citation: Dy. Graham, Proceedings from a Symposium at the XIIth International Workshop Gastroduodenal Pathology and Helicobacter pylori - Helsinki, 4 September 1999 - Chairman's introduction, HELICOBACT, 5, 2000, pp. S1-S1
Authors:
Graham, DY
Yamaoka, Y
Citation: Dy. Graham et Y. Yamaoka, Disease-specific Helicobacter pylori virulence factors: The unfulfilled promise, HELICOBACT, 5, 2000, pp. S3-S9
Authors:
McColl, K
Citation: K. Mccoll, Should non-invasive Helicobacter pylori testing replace endoscopy in investigation of dyspepsia?, HELICOBACT, 5, 2000, pp. S11-S15
Authors:
Sung, JJY
Citation: Jjy. Sung, Where are we with current therapy?, HELICOBACT, 5, 2000, pp. S17-S21
Authors:
O'Morain, C
Montague, S
Citation: C. O'Morain et S. Montague, Challenges to therapy in the future, HELICOBACT, 5, 2000, pp. S23-S26
Authors:
Bazzoli, F
Graham, DY
Holtmann, G
McColl, K
O'Morain, C
Sung, JJY
Citation: F. Bazzoli et al., Panel discussion - Unresolved issues, HELICOBACT, 5, 2000, pp. S27-S31
Authors:
Martino, G
Paoletti, M
Marcheggiano, A
D'Ambra, G
Delle Fave, G
Annibale, B
Citation: G. Martino et al., Duodenal ulcer relapse is not always associated with recurrence of H-pylori infection: A prospective three-year follow-up study, HELICOBACT, 4(4), 1999, pp. 213-217
Authors:
Ikezawa, K
Kashimura, H
Kojima, M
Aikawa, T
Nakahara, A
Mutoh, H
Tanaka, N
Citation: K. Ikezawa et al., Pretreatment antimicrobial susceptibilities of paired gastric Helicobacterpylori isolates: Antrum versus corpus, HELICOBACT, 4(4), 1999, pp. 218-221
Authors:
Gomollon, F
Ducons, JA
Ferrero, M
Cabezudo, JG
Guirao, R
Simon, MA
Montoro, M
Citation: F. Gomollon et al., Quadruple therapy is effective for eradicating Helicobacter pylori after failure of triple proton-pump inhibitor-based therapy: A detailed, prospective analysis of 21 consecutive cases, HELICOBACT, 4(4), 1999, pp. 222-225
Authors:
Plebani, M
Guariso, G
Fogar, P
Basso, D
Gallo, N
Zambon, CF
Mozrzymas, R
Celadin, M
Zacchello, F
Citation: M. Plebani et al., Effect of cagA status on the sensitivity of enzyme immunoassay in diagnosing Helicobacter pylori-infected children, HELICOBACT, 4(4), 1999, pp. 226-232
Authors:
Vincent, P
Michaud, L
de Lasalle, EM
Benon, B
Turck, D
Gottrand, M
Citation: P. Vincent et al., C-13-urea breath test and gastric mucosal colonization by Helicobacter pylori in children: Quantitative relation and usefulness for diagnosis of infection, HELICOBACT, 4(4), 1999, pp. 233-237
Authors:
Korzon, M
Sikorska-Wisniewska, G
Jankowski, Z
Kur, J
Banach, P
Citation: M. Korzon et al., Clinical and pathological importance of cagA-positive Helicobacter pylori strains in children with abdominal complaints, HELICOBACT, 4(4), 1999, pp. 238-242
Authors:
Zoorob, RJ
Jones, GN
Mainous, AG
Hagen, MD
Citation: Rj. Zoorob et al., Practice patterns for peptic ulcer disease: Are family physicians testing for H-pylori?, HELICOBACT, 4(4), 1999, pp. 243-248
Authors:
McCathey, SN
Shomer, NH
Schrenzel, MD
Whary, MT
Taylor, NS
Fox, JG
Citation: Sn. Mccathey et al., Colonization and tissue tropism of Helicobacter pylori and a novel urease-negative Helicobacter species in ICR mice are independent of route of exposure, HELICOBACT, 4(4), 1999, pp. 249-259
Authors:
Hammond, PD
Stutzenberger, FJ
Butler, RN
Read, LC
Davidson, GP
Citation: Pd. Hammond et al., Factors affecting the validity of the C-13-urea breath test for in vivo determination of Helicobacter pylori infection status in a mouse model, HELICOBACT, 4(4), 1999, pp. 260-265
Authors:
Adamek, RJ
Szymanski, C
Pfaffenbach, B
Citation: Rj. Adamek et al., Pantoprazole suppresses Helicobacter pylori without affecting cure, HELICOBACT, 4(4), 1999, pp. 266-271
Authors:
Rupnow, MFT
Owens, DK
Shachter, R
Parsonnet, J
Citation: Mft. Rupnow et al., Helicobacter pylori vaccine development and use: A cost-effectiveness analysis using the institute of medicine methodology, HELICOBACT, 4(4), 1999, pp. 272-280
Authors:
Boulton-Jones, JR
Logan, RPH
Citation: Jr. Boulton-jones et Rph. Logan, An inverse relation between cagA-positive strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma, HELICOBACT, 4(4), 1999, pp. 281-283
Authors:
Mahachai, V
Tangkijvanich, P
Wannachai, N
Sumpathanukul, P
Kullavanijaya, P
Citation: V. Mahachai et al., CagA and VacA: Virulence factors of Helicobacter pylori in thai patients with gastroduodenal diseases, HELICOBACT, 4(3), 1999, pp. 143-147
Authors:
Taylor, DE
Fedorak, RN
Sherburne, R
Citation: De. Taylor et al., Antigenic mimicry between Helicobacter pylori and gastric mucosa: Failure to implicate heat-shock protein Hsp60 using immunoelectron microscopy, HELICOBACT, 4(3), 1999, pp. 148-153
Authors:
Dore, MP
Graham, DY
Sepulveda, AR
Citation: Mp. Dore et al., Different penicillin-binding protein profiles in amoxicillin-resistant Helicobacter pylori, HELICOBACT, 4(3), 1999, pp. 154-161
Authors:
Mobley, HLT
Garner, RM
Chippendale, GR
Gilbert, JV
Kane, AV
Plaut, AG
Citation: Hlt. Mobley et al., Role of Hpn and NixA of Helicobacter pylori in susceptibility and resistance to bismuth and other metal ions, HELICOBACT, 4(3), 1999, pp. 162-169
Authors:
Kamada, T
Haruma, K
Komoto, K
Mihara, M
Sumii, K
Kajiyama, G
Citation: T. Kamada et al., Comparison of meal-stimulated serum gastrin response in Helicobacter pylori-positive duodenal ulcer and asymptomatic volunteers with and without H-pylori infection, HELICOBACT, 4(3), 1999, pp. 170-177
Authors:
Catalano, F
Branciforte, G
Catanzaro, R
Bentivegna, C
Cipolla, R
Nuciforo, G
Brogna, A
Citation: F. Catalano et al., Comparative treatment of Helicobacter pylori-positive duodenal ulcer usingpantoprazole at low and high doses versus omeprazole in triple therapy, HELICOBACT, 4(3), 1999, pp. 178-184
Authors:
Nguyen, TN
Barkun, AN
Fallone, CA
Citation: Tn. Nguyen et al., Host determinants of Helicobacter pylori infection and its clinical outcome, HELICOBACT, 4(3), 1999, pp. 185-197